游离DNA整合微生物与宿主信息作为脓毒症生物标志物
研究对脓毒症与非脓毒症ICU患者血浆cfDNA进行宏基因组测序,纵向整合cfDNA总量、人源cfDNA片段模式、感染病原体及微生物组成。脓毒症患者cfDNA总量显著升高且片段模式改变,整合信息的机器学习模型识别脓毒症与预测结局的AUC分别为0.992(95%CI 0.969-1.000)和0.802(95%CI 0.605-0.999)。
要点
- 脓毒症患者血浆cfDNA总量显著升高,人源cfDNA片段模式发生改变。
- 宏基因组测序检测细菌感染比血培养更敏感,并可同时检出病毒病原体。
- 整合多维cfDNA信息的机器学习模型可识别脓毒症并预测临床结局。
核心结论
- 整合单次宏基因组检测获得的多维cfDNA信息,可在ICU入科第一天诊断脓毒症并预测28天死亡率。
研究设计与样本
- 对脓毒症与非脓毒症ICU患者血浆cfDNA进行宏基因组测序,并纵向测量与整合评估cfDNA总量、人源片段模式、感染病原体及整体微生物组成。
主要发现
- 脓毒症患者cfDNA总量显著增加且人源cfDNA片段模式改变,片段信息可反映细胞氧化应激并提示疾病严重程度。
- 宏基因组测序检测细菌感染较血培养更敏感,并可同时检测病毒病原体。
- 脓毒症与非脓毒症患者之间、28天死亡率存活者与非存活者之间,在入ICU第一天及整个研究期间微生物组成存在差异。
- 整合全部信息的机器学习模型识别脓毒症AUC为0.992(95%CI 0.969-1.000),预测临床结局AUC为0.802(95%CI 0.605-0.999)。
关键数值与推荐
- 识别脓毒症的AUC为0.992(95%CI 0.969-1.000)。
- 预测临床结局的AUC为0.802(95%CI 0.605-0.999)。
临床怎么用
- 可考虑以单次宏基因组检测整合cfDNA定量、片段模式与微生物信息,辅助ICU脓毒症早期识别与结局风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cell-free DNA (cfDNA) is emerging as a biomarker for sepsis. Previous studies have been focused mainly on identifying blood infections or simply quantifying cfDNA. We propose that by characterizing multifaceted unexplored components, cfDNA could be more informative for assessing this complex syndrome. METHODS: We explored multiple aspects of cfDNA in septic and nonseptic intensive care unit (ICU) patients by metagenomic sequencing, with longitudinal measurement and integrative assessment of plasma cfDNA quantity, human cfDNA fragmentation patterns, infecting pathogens, and overall microbial composition. RESULTS: Septic patients had significantly increased cfDNA quantity and altered human cfDNA fragmentation pattern. Moreover, human cfDNA fragments appeared to comprise information about cellular oxidative stress and could indicate disease severity. Metagenomic sequencing was more sensitive than blood culture in detecting bacterial infections and allowed for simultaneous detection of viral pathogens. We found differences in microbial composition between septic and nonseptic patients and between survivors and nonsurvivors by 28-day mortality, both on the first day of ICU admission and across the study period. By integrating all the information into a machine learning model, we achieved improved performance in identifying sepsis and prediction of clinical outcome for ICU patients with areas under the curve of 0.992 (95% CI 0.969-1.000) and 0.802 (95% CI 0.605-0.999), respectively. CONCLUSIONS: We were able to diagnose sepsis and predict mortality as soon as the first day of ICU admission by integrating multifaceted cfDNA information obtained in a single metagenomic assay; this approach could provide important advantages for clinical management and for improving outcomes in ICU patients.
引用
- Jing Q, Leung CHC, Wu AR, et al. Cell-Free DNA as Biomarker for Sepsis by Integration of Microbial and Host Information. Clin Chem. 2022. PMID: 35771673. doi:10.1093/clinchem/hvac097
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。